IMMUTEP Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Feb 27, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-issuer, company-update
TL;DR
IMMUTEP Ltd (formerly Prima BioMed) filed a 6-K on 2/26/25. Standard foreign issuer report.
AI Summary
On February 26, 2025, IMMUTEP Ltd filed a Form 6-K. The company, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia, and operates in the Pharmaceutical Preparations sector. This filing is a report of a foreign private issuer.
Why It Matters
This filing indicates IMMUTEP Ltd is providing updated information to the SEC as a foreign private issuer, which is standard for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- February 26, 2025 (date) — Filing date
- Sydney, Australia (location) — Company headquarters
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC when they are required to make public certain information in their home country or for distribution to their security holders.
When was IMMUTEP Ltd previously known by another name?
IMMUTEP Ltd was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
What is IMMUTEP Ltd's fiscal year end?
IMMUTEP Ltd's fiscal year ends on June 30.
What is IMMUTEP Ltd's primary business sector?
IMMUTEP Ltd operates in the Pharmaceutical Preparations sector, with SIC code 2834.
What is the filing date of this Form 6-K?
This Form 6-K was filed on February 27, 2025, reporting information as of February 26, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 27, 2025 regarding IMMUTEP Ltd (PRRUF).